Year: 2025

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions Financial results for the full year 2024 – HighlightsSales of CHF 934.3 million (2023: CHF 1,074.4 million), down by -13.0% in Swiss francs and by -11.5% in local currencies; H2 sales decrease by -11.3% in local currencies Decline in sales mainly due to softness in the instrument business with biopharmaceutical companies globally and general market weakness in China Adjusted EBITDA of CHF 164.4 million (2023: CHF 220.6 million), adjusted EBITDA margin reached 17.6% (2023: 20.5%) Margins declined due to lower sales volume, but were partly offset by cost-reduction measures Adjusted net profit of CHF 103.1 million (2023: CHF 164.4 million), adjusted earnings...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge Intelligence, today announced that it will showcase its leading-edge embedded compute, Industrial IoT (IIoT) and out-of-band management solutions at Embedded Tech India Expo, co-located with Convergence India Expo, being held March 19–21, 2025, in Bharat Mandapam, New Delhi, India. Lantronix will display at booth #C248 in Hall 3 (Embedded Compute section). “Our presence at the Embedded Tech India Expo reinforces our dedication to delivering cutting-edge solutions that support India’s evolving technology landscape and its rapidly growing sectors in Smart Cities, Enterprise and Transportation,” said Mathi Gurusamy, chief strategy officer at Lantronix. “A global technology...

CALGARY, Alberta, March 11, 2025 (GLOBE NEWSWIRE) — TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or “we”) today announced its unaudited financial and operating results for the three months and year ended December 31, 2024.   All dollar figures are expressed in United States dollars (“USD”) unless otherwise stated. In the following discussion, the three months and the year ended December 31, 2024 may be referred to as “Q4 2024” and “2024”, respectively. The comparative three months and year ended December 31, 2023 may be referred to as “Q4 2023” and “2023”, respectively. Q4 2024 SUMMARY During Q4 2024, the Company:Reported net cash used in operating activities of $1.5 million and funds flow provided by operating activities of $1.0 million; Earned $19.6 million of oil and natural gas sales revenue on total...

RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today the pricing of an underwritten public offering of 12,962,962 shares of its common stock at a public offering price of $13.50 per share. The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $175.0 million. In addition, Mineralys has granted the underwriters a 30-day option to purchase up to an additional 1,944,444 shares of its common stock. All of the securities to be sold in the...

$250,000 top award goes to Matteo Paz in America’s longest running and most distinguished science and math competition TARRYTOWN, N.Y. and WASHINGTON, March 11, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s oldest and most prestigious science and math competition for high school seniors. Now in its 84th year, the competition celebrates and rewards young innovators who are applying their Science, Technology, Engineering and Math (STEM) talent and leadership skills to push the boundaries of discovery and address today’s pressing challenges. Forty finalists, including Matteo, were honored this evening during an award ceremony at the National...

Vancouver, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE: TUNG) (OTCQB: DEMRF) (FSE: RK9) (“American Tungsten” or the “Company”) announces that it has received a request from OTC Markets Group Inc. (“OTC Markets”) to issue this statement regarding recent promotional activity concerning its common shares (the “Common Shares”) traded on the OTCQB Marketplace. Promotional Activity On March 4, 2025, OTC Markets informed the Company that it became aware of certain promotional activities concerning American Tungsten and its Common Shares, including the distribution of digital marketing materials by Emerging Markets Consulting, LLC (“EMC”). These materials discussed the Company’s projects, its business model, and the tungsten industry in general....

VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it plans to release its fourth quarter 2024 results after market close on Wednesday, March 12, 2025. Conifex has scheduled a conference call at 8:00 AM Pacific time / 11:00 AM Eastern time the following morning March 13, 2025, to discuss its financial results. To participate in the call, please dial one of the following numbers: Toll-Free Access (Canada/US): 1-800-806-5484Local dial-in number: 416-340-9645Participant Pass Code: 1625539# A recording of the conference or transcript is available upon request. For further information, please contact: Trevor Pruden        Chief Financial Officer        investorrelations@conifex.com          About Conifex Timber Inc. Conifex and its subsidiaries’ primary...

Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation System HOLLISTER, Calif., March 11, 2025 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Pluristyx’s PluriFreeze™ product line, a cryopreservative and cell wash media system intended for use by customers who are developing next generation allogeneic cell therapies. Teknova is a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, while Pluristyx is a leading provider of induced Pluripotent Stem Cells (iPSCs), including immune evading and safety-switch enabled iPSCs, and other innovative...